FDA's Lillian Yin
This article was originally published in The Gray Sheet
Executive Summary
Director of the division of reproductive, abdominal, ear nose & throat and radiological devices in FDA's Office of Device Evaluation moves to the Center for Biologics Evaluation and Research in order to work on CBER's action plan for the regulation of devices ("The Gray Sheet" Dec. 7, p. 22). DRAERD Chief Medical Officer Dan Schultz is replacing Yin on an acting basis. Also leaving CDRH to join CBER is Mary Beth Jacobs, director of the division of life sciences within the Office of Science and Technology